ClinicalTrials.govpublic full text
Study on the Efficacy and Safety of VA Regimen Compared to "3+7" Regimen in Newly Diagnosed AML With NPM1 or IDH1/IDH2 Mutations
acute myeloid leukemia, npm1 mutation, idh1 mutation, idh2 mutation, venetoclax, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 893818
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.